Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone

Park, Y. H.; Kim, S.; Choi, Seok-Cheol; Ryoo, Baek Yeol; Yang, Sung Hyun; Cheon, Gi Jeong; Choi, Chang Woon; Lim, Sang Moo; Yoo, Ji Young; Lee, S.-S.

doi:10.1093/annonc/mdi234

Cited by 31 publications

(15 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8). There are few reports describing the use of FDG-PET/CT in the diagnosis of primary bone lymphoma [66]. The role of FDG-PET/CT for staging and restaging of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) is however firmly established [67,68].…”

Section: Primary Bone Lymphomamentioning

confidence: 99%

PET/CT in primary musculoskeletal tumours: a step forward

et al. 2010

View full text Add to dashboard Cite

Hybrid imaging with combined positron emission tomography/computed tomography (PET/CT) plays an important role in the staging and management of a wide variety of solid tumours. However, its use in the evaluation of musculoskeletal malignancy has not yet entered routine clinical practice. Cross-sectional imaging with magnetic resonance imaging (MR) and computed tomography have well-established roles but there is increasing evidence for the selective use of PET/CT in the management of these patients. The aims of this article are to review the current evidence and clinical applications of PET/CT in primary musculoskeletal tumours and discuss potential future developments using novel PET tracers and integrated PET/MR.

show abstract

Section: Primary Bone Lymphomamentioning

confidence: 99%

PET/CT in primary musculoskeletal tumours: a step forward

et al. 2010

View full text Add to dashboard Cite

show abstract

“…In addition, a previous study suggested that PET/CT is more accurate compared with bone ECT in assessing bone involvement by lymphoma (23). In addition, PET/CT has been demonstrated to be superior to CT and MRI, particularly in multifocal disease, and may be significant in the assessment of response to treatment (24). However, the imaging characteristics of PBL are variable, with detectable abnormalities, and nonspecific to the diagnosis for PBL.…”

Section: Discussionmentioning

confidence: 99%

Primary sternum diffuse large B-cell lymphoma: A case report and review of the literature

Tong

Zhang

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

Abstract. Primary bone lymphoma (PBL) is a rare disease, accounting for >1% of all cases of malignant lymphoma. Diffuse large B-cell lymphoma (DLBCL) is the most common histological type of PBL. The present study reported the case of a 68-year-old male with primary bone DLBCL, originally occurred in the sternum, which is a rare form of presentation. Computed tomography (CT), magnetic resonance imaging and bone emission CT were performed, followed by immunohistochemical analysis of a biopsy specimen, and the results were used to establish the diagnosis. At the time of diagnosis, no osseous involvement was observed. The clinical, radiological and histological features of PBL can mimic other medical conditions, thereby making the diagnosis difficult, and frequently leading to delays in treatment. The present study investigated the clinical features, management and prognosis of PBL, and reviewed previous relevant cases.

show abstract

“…However, there have been only a few reports suggesting superior clinical usefulness of PET to MRI in the assessment of bone involvement of ML. [12][13][14] Recently, diffusion-weighted MRI (DWI) has been spreading for the purpose of distinguishing malignancies from benign lesions in various body regions other than central nervous system such as the cervical lymph node and nasal cavity. [15][16][17] In bone tumors, apparent diffusion coefficient value on DWI has been reported to be useful for monitoring the therapeutic response of primary bone sarcomas.…”

Section: Discussionmentioning

confidence: 99%